Move to 'de-risk' supply chains is leading some biotech firms to consider using Indian drug manufacturers to produce active pharmaceutical ingredient for clinical trials or other work
US vaccine maker says it signed agreements with Shanghai officials on developing mRNA vaccines in China. Local news outlet says it is a $1-billion deal
The European Union is set to lay out strategies on 'de-risking' trade with China and other potential military rivals
AstraZeneca is looking at spinning off its business in China - listing it in Hong Kong or Shanghai - in hope that the move will protect it from rising tensions between global powers, sources have said
The US has added 43 firms – mostly Chinese – to its Entity List, banning them from receiving US exports for activities such as training army pilots and developing hypersonic missiles
China hawks in Washington blame US investors for transferring capital and valuable know-how to Chinese tech companies that could help advance Beijing's military
Tech entrepreneurs say they're looking to base companies abroad, disillusioned with Xi Jinping's policies, and happy to play down their Chinese identity amid growing trade rivalry with the US
Some 24 Chinese firms have changed auditors since 2022, according to an analysis of filings by Nikkei, which said many did that to avoid being delisted from US exchanges
The latest additions includes units of genomics giant BGI, which was linked to repression of ethnic minorities, plus firms linked to ballistic missiles, or surveillance equipment used by Burma’s military
China has a 'stunning lead' in most of the 44 critical emerging technologies, an Australian Strategic Policy Institute study said, adding that democratic nations need to collaborate more
Genetic resources and finance are tipped to be key issues on a legally binding UN agreement to protect the world's oceans
The US government plans to bar investment in some Chinese tech companies, to stop American money pouring into sensitive sectors such as chips for artificial intelligence